Elevated Lipoprotein(a) and Coronary Artery Calcium Score Linked to ASCVD Risk
Investigators examined the independent and joint association of lipoprotein(a) and coronary artery calcium with risk for atherosclerotic cardiovascular disease.
Investigators examined the independent and joint association of lipoprotein(a) and coronary artery calcium with risk for atherosclerotic cardiovascular disease.
A study was conducted to determine the relationship between breast arterial calcification and risk for atherosclerotic cardiovascular disease.
Researchers evaluated the ability to improve risk stratification of patients with ASCVD via a novel machine-learning model.
For patients with established atherosclerotic cardiovascular disease, the treatment benefit of smoking cessation is equivalent to the use of targeted pharmaceutical interventions in persistent smokers.
Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.
The researchers believe the results of this study highlight the need for an effective screening tool for thyroid cysts among the general population.
The goal of this study was to determine the relationship between subclinical coronary artery disease and the severity of nonalcoholic fatty liver disease.
Researchers investigate whether asymptomatic atherosclerotic CVD can be prevented with an aggressive medical treatment that reduces LDL cholesterol to <60 mg/dl.
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
This study looked at 2946 individuals without cardiovascular disease who were assessed to have intermediate ASCVD risk and underwent electrocardiography.